Related Experiment Videos

Bleomycin: action on growth of oncogenic RNA viruses and on cell transformation

    Archives of Virology
    |January 1, 1975
    PubMed

    Insights

    Bleomycin (BLM) effectively inhibits Rous Sarcoma Virus replication by blocking cell proliferation and DNA synthesis in chick embryo fibroblasts. This antiviral effect is most pronounced during early stages of infection, impacting viral RNA transcription.

    Area of Science:

    • Virology
    • Molecular Biology
    • Cell Biology

    Background:

    • Rous Sarcoma Virus (RSV) transformation induces changes in chick embryo fibroblasts.
    • Bleomycin (BLM) is known to inhibit cell proliferation and DNA synthesis.

    Purpose of the Study:

    • To investigate the effect of Bleomycin (BLM) on cell proliferation and Rous Sarcoma Virus (RSV) replication.
    • To determine the mechanism by which BLM affects RSV growth in transformed cells.

    Main Methods:

    • Focus assay to determine cell transformation.
    • Treatment of infected and transformed chick embryo fibroblasts with Bleomycin (BLM).
    • Assessment of cell proliferation, DNA synthesis, and virus replication.

    Main Results:

    • Bleomycin (BLM) selectively inhibits DNA synthesis and cell proliferation in chick embryo fibroblasts.
    • BLM significantly reduces foci formation in transformed cells.
    • BLM inhibits RSV replication in both growing and confluent cells, with a more pronounced effect during the first 24 hours post-infection.
    • BLM has a limited effect on virus growth in already transformed cells.

    Conclusions:

    • Bleomycin (BLM) inhibits Rous Sarcoma Virus (RSV) growth primarily by blocking host cell proliferation.
    • The timing of BLM application is critical, as its effect is linked to the requirement of cell division for viral RNA transcription initiation.

    Related Concept Videos